Last reviewed · How we verify
NCT03677791
Virtual 360°-Tour in Coronary Computed Tomography
NA trial testing Virtual tour in coronary computed tomography - 360° counselling environment in Coronary Artery Disease in 86 participants. Completed in 15 May 2022.
15 May 2022
Quick facts
| Lead sponsor | University of Oulu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 86 |
| Start date | 17 June 2020 |
| Primary completion | 15 May 2022 |
| Estimated completion | 15 May 2022 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- Virtual tour in coronary computed tomography - 360° counselling environment
- Current practice — full drug profile →
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Anxiety — all drugs for Anxiety →
- Fear — all drugs for Fear →
Sponsor
University of Oulu
Who can join
18 and older, any sex, with Coronary Artery Disease or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to evaluate the effectiveness of the virtual 360° counselling environment in the anxiety and process time of the patients coming to CCTA (coronary computed tomography angiography). The virtual, 360° environment 'Virtual 360°-tour in coronary computed tomography' uses 360°- technology based on spherical panorama images and resembles the spaces of the hospital according to the patient's pathway in CT-examination and provides information to the patient at various stages of the pathway.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03677791
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other University of Oulu trials
Trials by the same sponsor.
- NCT07381933 — The Effect of Consumed Berries on Extracellular Vesicle Signalling in the Body · NA · recruiting
- NCT07280624 — Diagnostic PCR Panel in Children With Acute Gastrointestinal Symptoms · NA · not yet recruiting
- NCT05494684 — Effectiveness of Multisensoral Nature-based Intervention in Hospitalized Children During Venous Blood Sampling · NA · not yet recruiting
- NCT06711393 — The Effectiveness of Exergaming for Older People Mobility and Balance · NA · not yet recruiting
- NCT06171867 — PNEUMACRIT Device for Neonatal Cardio Respiratory Monitoring · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03677791 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oulu
- Last refreshed: 6 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03677791.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing